DMAC DiaMedica Therapeutics Inc.
$8.38
DiaMedica Therapeutics Inc. (DMAC) Earnings News
Earnings press releases, previews and reviews for DiaMedica Therapeutics Inc. (DMAC), newest first. Our most recent is review: DiaMedica's Narrow Miss Matters Less Than Its Shrinking Runway and Slipping Timelines Ahead of Two Binary Catalysts.
Friday
November 13, 2026
9:41 AM ET
DiaMedica's Narrow Miss Matters Less Than Its Shrinking Runway and Slipping Timelines Ahead of Two Binary Catalysts
Earnings Whispers · Review
Thursday
November 12, 2026
4:30 PM ET
DiaMedica Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights
Thursday
November 5, 2026
12:14 PM ET
DiaMedica Heads Into Q3 Near Highs as Stroke Enrollment and Cash Runway Face Scrutiny
Earnings Whispers · Preview
Thursday
November 5, 2026
8:45 AM ET
DiaMedica Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Business Update November 13, 2026
Monday
August 10, 2026
4:30 PM ET
DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
Tuesday
August 4, 2026
4:30 PM ET
DiaMedica Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Business Update August 11, 2026